438531-52-3 Purity
---
If you have any other questions or need other size, please get a quote.
The molecular formula of Mestinon is C9H13BrN2O2.
The molecular weight of Mestinon is 261.12 g/mol.
The parent compound of Mestinon is Pyridostigmine (CID 4991).
The synonyms of Mestinon include PYRIDOSTIGMINE BROMIDE, Regonol, and Kalimin.
Mestinon is approved by the FDA to treat myasthenia gravis and to reverse the effects of muscle relaxants.
Mestinon is being studied as an investigational drug to treat HIV infection.
Mestinon binds reversibly to acetylcholinesterase active sites, preventing the breakdown of acetylcholine. This leads to an accumulation of acetylcholine at cholinergic synapses and facilitates impulse transmission across the neuromuscular junction.
Mestinon, through muscarinic receptors, increases the contraction of bronchial and intestinal smooth muscles and stimulates exocrine glands' secretions. Additionally, it causes paralysis of skeletal muscles through nicotinic receptors.
Mestinon is used as a reversible blocking agent to prevent organophosphates from binding to acetylcholinesterase receptors, protecting the nervous system from the effects of nerve agents such as Soman.
Some other identifiers for Mestinon include CAS number 101-26-8, EC number 202-929-9, UNII KVI301NA53, ChEMBL ID CHEMBL812, and KEGG ID D00487.